References
- Colgan, S. P.; Eltzschig, H. K.; Eckle, T.; Thompson, L. F. Physiological Roles for ecto-5′-nucleotidase (CD73). Purinergic Signal. 2006, 2, 351–360.
- Zukowska, P.; Kutryb-Zajac, B.; Toczek, M.; Smolenski, R. T.; Slominska, E. The Role of Ecto-5′-Nucleotidase in Endothelial Dysfunction and Vascular Pathologies. Pharmacol. Rep. 2015, 67, 675–681.
- Stagg, J.; Smyth, M. J. Extracellular Adenosine Triphosphate and Adenosine in Cancer. Oncogene 2010, 29, 5346–5358.
- Rockenbach, L.; Braganhol, E.; Dietrich, F.; Figueiró, F.; Pugliese, M.; Edelweiss, M. I. A.; Morrone, F. B.; Sévigny, J.; Battastini, A. M. O. NTPDase3 and Ecto-5′-Nucleotidase/CD73 Are Differentially Expressed during Mouse Bladder Cancer Progression. Purinergic Signal 2014, 10, 421–430.
- Bavaresco, L.; Bernardi, A.; Braganhol, E.; Cappellari, A. R.; Rockenbach, L.; Farias, P. F.; Wink, M. R.; Delgado-Cañedo, A.; Battastini, A. M. O. The Role of Ecto-5′-Nucleotidase/CD73 in Glioma Cell Line Proliferation. Mol. Cell. Biochem. 2008, 319, 61–68.
- Spychala, J. Tumor-Promoting Functions of Adenosine. Pharmacol. Ther. 2000, 87, 161–173.
- Wang, L.; Zhou, X.; Zhou, T.; Ma, D.; Chen, S.; Zhi, X.; Yin, L.; Shao, Z.; Ou, Z.; Zhou, P.; et al. Ecto-5′-Nucleotidase Promotes Invasion, Migration and Adhesion of Human Breast Cancer Cells. J. Cancer Res. Clin. Oncol. 2008, 134, 365–372.
- Rockenbach, L.; Bavaresco, L.; Fernandes Farias, P.; Cappellari, A. R.; Barrios, C. H.; Bueno Morrone, F.; Oliveira Battastini, A. M. Alterations in the Extracellular Catabolism of Nucleotides Are Involved in the Antiproliferative Effect of Quercetin in Human Bladder Cancer T24 Cells. Urol. Oncol. 2013, 31, 1204–1211.
- Figueiró, F.; Mendes, F. B.; Corbelini, P. F.; Janarelli, F.; Jandrey, E. H.; Russowsky, D.; et al. A Monastrol-Derived Compound, LaSOM 63, Inhibits Ecto-5'nucleotidase/CD73 Activity and Induces Apoptotic Cell Death of Glioma Cell Lines. Anticancer Res. 2014, 34, 1837–1842.
- Knapp, K.; Zebisch, M.; Pippel, J.; El-Tayeb, A.; Müller, C. E.; Sträter, N. Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling. Structure 2012, 20, 2161–2173.
- Landgraf, M.; McGovern, J. A.; Friedl, P.; Hutmacher, D. W. Rational Design of Mouse Models for Cancer Research. Trends Biotechnol. 2018, 36, 242–251.
- Dine, J.; Deng, C. X. Mouse Models of BRCA1 and Their Application to Breast Cancer Research. Cancer Metastasis Rev. 2013, 32, 25–37.
- Zukowska, P.; Kutryb-Zajac, B.; Jasztal, A.; Toczek, M.; Zabielska, M.; Borkowski, T.; Khalpey, Z.; Smolenski, R. T.; Slominska, E. M. Deletion of CD73 in Mice Leads to Aortic Valve Dysfunction. Biochim. Biophys. Acta. 2017, 1863, 1464–1472.
- Smolenski, R. T.; Lachno, D. R.; Ledingham, S. J.; Yacoub, M. H. Determination of Sixteen Nucleotides, Nucleosides and Bases Using High-Performance Liquid Chromatography and Its Application to the Study of Purine Metabolism in Hearts for Transplantation. J. Chromatogr. 1990, 527, 414–420.
- Geoghegan, J. C.; Diedrich, G.; Lu, X.; Rosenthal, K.; Sachsenmeier, K. F.; Wu, H.; Dall'Acqua, W. F.; Damschroder, M. M. Inhibition of CD73 AMP Hydrolysis by a Therapeutic Antibody with a Dual, Non-Competitive Mechanism of Action. MABS 2016, 8, 454–467.
- Koszałka, P.; Pryszlak, A.; Gołuńska, M.; Kolasa, J.; Stasiłojć, G.; Składanowski, A.; Bigda, J. Inhibition of CD73 Stimulates the Migration and Invasion of B16F10 Melanoma Cells in Vitro, but Results in Impaired Angiogenesis and Reduced Melanoma Growth in Vivo. Oncol. Rep. 2014, 31, 819–827.
- Wang, L.; Fan, J.; Thompson, L. F.; Zhang, Y.; Shin, T.; Curiel, T. J.; Zhang, B. CD73 Has Distinct Roles in Nonhematopoietic and Hematopoietic Cells to Promote Tumor Growth in Mice. J. Clin. Invest. 2011, 121, 2371–2382.